Related Experiment Video
Updated: Sep 11, 2025

03:43
Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
Published on: September 13, 2022
5.6K
Emergent cervical cerclage: experience from a tertiary center.
Inês Tlemçani1, Inês Martins2, Mónica Centeno2
1Dep. Obstetrics, Santa Maria University Hospital, Lisbon, Portugal.
Summary
Emergent cerclage can prolong pregnancy in cases of cervical insufficiency, improving outcomes. Earlier diagnosis of cervical insufficiency is linked to shorter latency and increased infection risk, highlighting the need for careful management.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
Background:
- Cervical insufficiency (CI) is a major cause of late miscarriage and preterm birth (PTB) before 27 weeks.
- Emergent cerclage is effective for prolonging pregnancy and improving neonatal outcomes in cases of painless cervical dilation between 14 and 24 weeks.
Purpose of the Study:
- To evaluate the obstetric and neonatal outcomes of pregnancies with cervical insufficiency requiring emergent cerclage placement.
Main Methods:
- Retrospective cohort study at a European tertiary care university hospital.
- Included singleton pregnancies with painless midtrimester cervical dilation >1 cm, gestational age 14-24 weeks, and no signs of chorioamnionitis.
- Assessed subclinical infection via amniocentesis in cases of membrane exposure or sludge; primary outcome was delivery after 28 weeks.
Main Results:
- 44% of 18 women delivered after 28 weeks, with a median pregnancy prolongation of 49.3 days.
- Overall survival rate was 66.7%, viable fetal survival 72.2%, and neonatal survival 92.3%.
- Earlier diagnosis (<20 weeks) correlated with shorter latency and higher preterm chorioamnionitis rates (p<0.05).
Conclusions:
- Earlier diagnosis of cervical insufficiency is associated with shorter latency and increased risk of preterm chorioamnionitis.
- Emphasizes the importance of infection screening and individualized management for high-risk pregnancies.
- Suggests future research on optimizing patient selection and adjunctive therapies for emergent cerclage.

